Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Reiteration

Reiteration

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

On Semiconductor Analysts Express Caution Post Q3 Over Its Margins Amid Macro Downturn

By Anusuya Lahiri
November 1, 3:32 PM
ON Semiconductor Corp (NASDAQ:ON) reported third-quarter FY22 revenue growth of 26% year-on-year to $2.19 billion, beating the consensus of…

ON

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Visa Or Mastercard: Which One Will Perform Better? This Analyst Picks His Favorite

By Anusuya Lahiri
November 1, 3:31 PM
Mizuho analyst Dan Dolev maintained Mastercard Inc (NYSE:MA) with a Buy and lowered the price target from $385 to $380. Dolev reiterated…

MA

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech

Analysts Highlight Global Payments’ Widening Gap With Fiserv In Merchant Acquiring

By Anusuya Lahiri
November 1, 2:54 PM
Mizuho analyst Dan Dolev reiterated Neutral on Global Payments Inc (NYSE:GPN) with a $132 price target reflecting weak and unreliable results. The 3Q 2022…

EVOP

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Movers
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech
  • Trading Ideas

Varonis’ Guidance Cut Triggers Analyst Downgrades, Price Cuts

By Anusuya Lahiri
November 1, 1:48 PM
Needham analyst Alex Henderson maintained Varonis Systems (NASDAQ:VRNS) with a Buy and lowered the price target from $32 to $26. Varonis shares…

VRNS

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Movers
  • News
  • Reiteration
  • Trading Ideas

As Stock Is Down 34% This Year, 3 NXP Semiconductors Analysts Weigh In On Results, Guidance

By Priya Nigam
November 1, 11:14 AM
NXP Semiconductors NV (NASDAQ: NXPI) Monday announced mixed third-quarter earnings and downbeat guidance. Raymond James On NXP Semiconductors

NXPI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

WEX Analyst Highlights Cost Savings, Cross-Sell Revenue Potential Post Q3 Beat

By Anusuya Lahiri
October 31, 3:28 PM
Credit Suisse analyst Nik Cremo reiterated Neutral on WEX Inc (NYSE:WEX) with a $195 price target. WEX’s Q3 2022 revenue exceeded consensus…

WEX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Price Target
  • Reiteration
  • Trading Ideas

Analysts Slash Y-mAbs Therapeutics Price Targets As Uncertainty Looms Over Neuroblastoma Hopeful

By Vandana Singh
October 31, 3:01 PM
On Friday, FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 16 to 0 that Y-mAbs Therapeutics Inc (NASDAQ:YMAB) did not provide…

YMAB

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Nvidia Is The Best Artificial Intelligence and Machine Learning Play, Analyst Says

By Anusuya Lahiri
October 31, 2:41 PM
Mizuho analyst Vijay Rakesh reiterated a Buy on Nvidia Corp (NASDAQ:NVDA) with a $205 price target. Recent events have significantly impacted the…

META

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • News
  • Price Target
  • Reiteration

Mondelez Remains This Analyst’s Top Pick For Global Staples Investors Despite FX Drag

By Shivani Kumaresan
October 31, 1:35 PM
Mizuho analyst John Baumgartner reiterated a Buy rating on the shares of Mondelez International Inc (NASDAQ: MDLZ) and lowered the price target from $75 to $70.

MDLZ

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Price Target
  • Reiteration

Etsy Is Down 54% This Year, Now A BofA Analyst Has Cut Its Price Target Ahead Of Earnings

By Priya Nigam
October 31, 11:13 AM
Etsy Inc (NASDAQ: ETSY) is scheduled to report its third-quarter earnings on Wednesday, after market close.

AMZN

Posts pagination

Previous 1 … 349 350 351 … 399 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service